These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 12077597)
1. Nail pigmentation caused by hydroxyurea: report of 9 cases. Aste N; Fumo G; Contu F; Aste N; Biggio P J Am Acad Dermatol; 2002 Jul; 47(1):146-7. PubMed ID: 12077597 [TBL] [Abstract][Full Text] [Related]
2. Transverse melanonychia and palmar hyperpigmentation secondary to hydroxyurea therapy. Schoenfeld J; Tulbert BH; Cusack CA Cutis; 2017 May; 99(5):E2-E4. PubMed ID: 28632807 [No Abstract] [Full Text] [Related]
3. Longitudinal, transverse, and diffuse nail hyperpigmentation induced by hydroxyurea. Hernández-Martín A; Ros-Forteza S; de Unamuno P J Am Acad Dermatol; 1999 Aug; 41(2 Pt 2):333-4. PubMed ID: 10426924 [TBL] [Abstract][Full Text] [Related]
4. Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject. Saraceno R; Teoli M; Chimenti S Clin Ther; 2008 Jul; 30(7):1324-9. PubMed ID: 18691992 [TBL] [Abstract][Full Text] [Related]
5. Twenty-Nail Transverse Melanonychia Induced by Hydroxyurea: Case Report and Review of the Literature. Osemwota O; Uhlemann J; Rubin A J Drugs Dermatol; 2017 Aug; 16(8):814-815. PubMed ID: 28809997 [TBL] [Abstract][Full Text] [Related]
6. Melanonychia and mucocutaneous hyperpigmentation from hydroxyurea use for the treatment of essential thrombocytosis. Karanth SS; Gupta A; Prabhu M Singapore Med J; 2014 Jan; 55(1):e7-8. PubMed ID: 24452985 [TBL] [Abstract][Full Text] [Related]
7. Mucocutaneous lesions and nail pigmentation in a patient with essential thrombocytosis. Calleja Algarra A; Miguel RA; Tous Romero F; Maroñas Jiménez L Aust Fam Physician; 2017; 46(4):222-224. PubMed ID: 28376576 [No Abstract] [Full Text] [Related]
8. Nail pigmentation due to hydroxycarbamide. Ceulen RP; Frank J; Poblete-Gutiérrez P Int J Dermatol; 2007 Nov; 46 Suppl 3():13-5. PubMed ID: 17973880 [TBL] [Abstract][Full Text] [Related]
9. [Longitudinal melanonychia and hydroxyurea]. Pirard C; Michaux JL; Bourlond A Ann Dermatol Venereol; 1994; 121(2):106-9. PubMed ID: 7979014 [TBL] [Abstract][Full Text] [Related]
10. Cutaneous adverse reactions to hydroxyurea in patients with intermediate thalassemia. Zargari O; Kimyai-Asadi A; Jafroodi M Pediatr Dermatol; 2004; 21(6):633-5. PubMed ID: 15575845 [TBL] [Abstract][Full Text] [Related]
11. A case of hydroxyurea-induced longitudinal melanonychia. Utaş S; Kulluk P Int J Dermatol; 2010 Apr; 49(4):469-70. PubMed ID: 20465711 [No Abstract] [Full Text] [Related]
12. Hydroxyurea-Induced Oral Hyperpigmentation: A Case Report and Review of the Literature. Veillet-Lemay G; Haber RM J Cutan Med Surg; 2019; 23(1):111-113. PubMed ID: 30232899 [No Abstract] [Full Text] [Related]
13. Melanonychia and mucocutaneous hyperpigmentation due to hydroxyurea use in an HIV-infected patient. Laughon SK; Shinn LL; Nunley JR Int J Dermatol; 2000 Dec; 39(12):928-31. PubMed ID: 11168664 [No Abstract] [Full Text] [Related]
14. Hydroxyurea-induced melanonychia concomitant with a dermatomyositis-like eruption. Oh ST; Lee DW; Lee JY; Cho BK J Am Acad Dermatol; 2003 Aug; 49(2):339-41. PubMed ID: 12894095 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal melanonychia on multiple nails induced by hydroxyurea. Nguyen AL; Körver JE; Theunissen CC BMJ Case Rep; 2017 Feb; 2017():. PubMed ID: 28202485 [No Abstract] [Full Text] [Related]
16. Cutaneous manifestations of hydroxyurea therapy in childhood: case report and review. Issaivanan M; Mitu PS; Manisha C; Praveen K Pediatr Dermatol; 2004; 21(2):124-7. PubMed ID: 15078351 [TBL] [Abstract][Full Text] [Related]
17. Nail and skin hyperpigmentation associated with hydroxyurea therapy for polycythemia vera. Gropper CA; Don PC; Sadjadi MM Int J Dermatol; 1993 Oct; 32(10):731-3. PubMed ID: 8225715 [No Abstract] [Full Text] [Related]